Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

52 insider filings · Latest: Jul 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 24, 2026Jun 26 1:55 AMBruce BoothDirector
Sale
134,720$100.51$13.5M597,047(I)

View →

Jun 23, 2026Jun 26 1:55 AMBruce BoothDirector
Sale
1,408$99.98$140.8K613,589(I)

View →

Jun 25, 2026Jun 25 10:00 PMNoah GoodmanChief Business Officer
Sale
5,000$114.00$570.0K50,195.438(D)

View →

Jun 25, 2026Jun 25 9:26 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
67,329$99.87$6.7M

View →

Jun 25, 2026Jun 25 9:25 PMAtlas Venture Fund X, LP
Proposed Sale
480,992$99.87$48.0M

View →

Jun 25, 2026Jun 25 8:27 PMNOAH GOODMAN
Proposed Sale
5,000$99.87$499.4K

View →

Jun 24, 2026Jun 24 9:30 PMAtlas Venture Fund X, LP
Proposed Sale
118,178$98.25$11.6M

View →

Jun 24, 2026Jun 24 9:29 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
16,542$98.25$1.6M

View →

Jun 23, 2026Jun 23 10:14 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
173$99.45$17.2K

View →

Jun 23, 2026Jun 23 10:14 PMAtlas Venture Fund X, LP
Proposed Sale
1,235$99.45$122.8K

View →

Jun 22, 2026Jun 23 1:02 AMBruce BoothDirector
Sale
31,798$103.75$3.3M613,762(I)

View →

Jun 22, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
246,330$98.52$24.3M617,663(I)

View →

Jun 18, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
115,056$91.01$10.5M647,914(I)

View →

Jun 17, 2026Jun 23 1:01 AMBruce BoothDirector
Sale
116,812$90.34$10.6M662,042(I)

View →

Jun 22, 2026Jun 22 9:47 PMNoah GoodmanChief Business Officer
Sale
2,500$99.00$247.5K50,195.438(D)

View →

Jun 22, 2026Jun 22 9:28 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
34,152$90.43$3.1M

View →

Jun 22, 2026Jun 22 9:28 PMAtlas Venture Fund X, LP
Proposed Sale
243,976$90.43$22.1M

View →

Jun 22, 2026Jun 22 8:46 PMNOAH GOODMAN
Proposed Sale
2,500$90.43$226.1K

View →

Jun 18, 2026Jun 18 9:35 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
14,128$89.90$1.3M

View →

Jun 18, 2026Jun 18 9:35 PMAtlas Venture Fund X, LP
Proposed Sale
100,928$89.90$9.1M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 3 of 3